Novartis invests over $500 in new Singapore facility

Singapore: Novartis is investment over $500 million for a new state-of-the-art biotechnology production site in Singapor...

October 31, 2012 | Wednesday | News
Institute for Systems Biology, ABSciex to collaborate

Singapore: Institute for Systems Biology (ISB) and AB SCIEX have signed a multi-year agreement to collaborate on the dev...

February 7, 2013 | Thursday | News
Studies on MabThera delivery method positive

Singapore: Two studies by Roche has demonstrated that a fixed dose of MabThera (rituximab) can be administered subcutane...

December 10, 2012 | Monday | News
Merck to develop processes for stem cell cultures

Singapore: Merck Millipore, the life science division of Merck, and the Institute of Bioprocess Engineering and Pharmace...

September 20, 2012 | Thursday | News
Scientists find cellular origin of cervical cancer

Singapore: A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS)...

June 14, 2012 | Thursday | News
Analytical instruments market to soar in China

Singapore: China is soon expected to become a sales hub for lab analytical instruments as international companies speed ...

November 26, 2012 | Monday | Analysis
China Biologic to report Q2 results

Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, will rel...

July 31, 2013 | Wednesday | Company results
Oncotest, Debiopharm identify biomarker candidates

Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first bio...

April 25, 2013 | Thursday | News
EMA recommends MSD's melanoma drug

Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...

May 27, 2015 | Wednesday | Regulatory
Intrexon appoints new VP and CIO

Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business deve...

November 20, 2013 | Wednesday | News
China Biologic clocks sales of $53.6 mn

Singapore: China Biologic Products reported its unaudited financial results for the second quarter of 2013. Total sales ...

August 7, 2013 | Wednesday | Company results
China Biologic reports 21.1% growth in sales revenue

Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announce...

August 10, 2012 | Friday | Company results
GE launches new software for molecular screening

Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for...

June 12, 2013 | Wednesday | News
Biochips firm AyoxxA gets $3.37 million funding

Singapore: AyoxxA Biosystems, an international biotechnology company, has closed a $3.37 million (2.6 million Euro) seri...

September 21, 2012 | Friday | News
China's JHL Biotech raises $35 million

Singapore: China based emerging biopharmaceutical company, JHL Biotech, has closed a Series B financing round of $35 mil...

June 23, 2014 | Monday | News
bioCSL inks a deal with Immucor

Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and N...

July 21, 2014 | Monday | News
Promega opens new facility in Shanghai

Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biologi...

November 19, 2012 | Monday | News
Novel protein complex to combat gastric cancer

Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI) at National University of Singapore (NU...

July 8, 2014 | Tuesday | News